VAERS reports by lot

Pfizer COVID-19 lot HF9299: VAERS reports

39 VAERS reports list lot HF9299 as a Pfizer COVID-19 vaccine, received between 2023-10-15 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
39
Reports
10%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular3523%
General / Systemic (non-local)2516%
Neurological2315%
Injection-site / Local reaction2315%
Thrombotic / Hematological139%
Dermatological (non-injection-site)128%
Gastrointestinal107%
Allergic / Anaphylactic43%
Respiratory32%
Musculoskeletal21%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania5
Kentucky5
Massachusetts4
Texas4
Virginia2
California2
Florida2
Georgia2
North Carolina1
New Jersey1
Indiana1
Maine1

Reports by month received

2023-104
2023-1111
2023-124
2024-019
2024-021
2024-031
2024-069

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.